Trials / Completed
CompletedNCT05154955
A Safety and Tolerability Study of 10XB-101 Injection in Adult Subjects With Submental Fat
A Multi-Center, Randomized, Double-Blinded, Vehicle-Controlled Study of the Safety and Efficacy of 10XB-101 in Adult Subjects With Submental Fat
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 51 (actual)
- Sponsor
- 10xBio, LLC · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this research study is to determine the safety and efficacy of 10XB-101 vs. vehicle (placebo) for adults with excessive submental fat (SMF).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 10XB-101 Solution for Injection | One of the three concentrations of 10XB-101 will be evaluated against placebo for submental fat reduction. |
| DRUG | 10XB-101 Vehicle Solution for Injection | This is the placebo control |
Timeline
- Start date
- 2021-10-19
- Primary completion
- 2024-03-19
- Completion
- 2024-03-19
- First posted
- 2021-12-13
- Last updated
- 2025-06-29
Locations
4 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05154955. Inclusion in this directory is not an endorsement.